| Product Code: ETC13384481 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Immunology Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Immunology Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Immunology Market Revenues & Volume, 2021 & 2031F |
3.3 North America Immunology Market - Industry Life Cycle |
3.4 North America Immunology Market - Porter's Five Forces |
3.5 North America Immunology Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Immunology Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 North America Immunology Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 North America Immunology Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 North America Immunology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Immunology Market Trends |
6 North America Immunology Market, 2021 - 2031 |
6.1 North America Immunology Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Immunology Market, Revenues & Volume, By Monoclonal Antibody (mAb), 2021 - 2031 |
6.1.3 North America Immunology Market, Revenues & Volume, By Fusion Proteins, 2021 - 2031 |
6.1.4 North America Immunology Market, Revenues & Volume, By Immunosuppressants, 2021 - 2031 |
6.1.5 North America Immunology Market, Revenues & Volume, By Polyclonal Antibody (pAb), 2020 - 2028 |
6.1.6 North America Immunology Market, Revenues & Volume, By Others, 2020 - 2028 |
6.2 North America Immunology Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Immunology Market, Revenues & Volume, By Rheumatoid Arthritis, 2021 - 2031 |
6.2.3 North America Immunology Market, Revenues & Volume, By Psoriatic Arthritis, 2021 - 2031 |
6.2.4 North America Immunology Market, Revenues & Volume, By Plaque Psoriasis, 2021 - 2031 |
6.2.5 North America Immunology Market, Revenues & Volume, By Ankylosing Spondylitis, 2021 - 2031 |
6.2.6 North America Immunology Market, Revenues & Volume, By Inflammatory Bowel Disease, 2020 - 2028 |
6.2.7 North America Immunology Market, Revenues & Volume, By Prophylaxis of Organ Rejection, 2020 - 2028 |
6.2.8 North America Immunology Market, Revenues & Volume, By Others, 2020 - 2028 |
6.3 North America Immunology Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Immunology Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.3.3 North America Immunology Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.3.4 North America Immunology Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
7 North America Immunology Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Immunology Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.1 United States (US) Immunology Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.2 Canada Immunology Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.2.3 Rest of North America Immunology Market, Revenues & Volume, By Drug Class, 2021 - 2031 |
7.3 North America Immunology Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
7.3.1 United States (US) Immunology Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.2 Canada Immunology Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.3 Rest of North America Immunology Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4 North America Immunology Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.4.1 United States (US) Immunology Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.4.2 Canada Immunology Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.4.3 Rest of North America Immunology Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 North America Immunology Market Key Performance Indicators |
9 North America Immunology Market - Export/Import By Countries Assessment |
10 North America Immunology Market - Opportunity Assessment |
10.1 North America Immunology Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Immunology Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10.3 North America Immunology Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
10.4 North America Immunology Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 North America Immunology Market - Competitive Landscape |
11.1 North America Immunology Market Revenue Share, By Companies, 2022 |
11.2 North America Immunology Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here